About Malook Pharmaceuticals Private Limited
Data last updated:
Malook Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 08 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24302DL2019PTC352339. Its GSTIN is 07AAMCM7960N1ZM (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anita Sharma and Shailesh Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Building No 19 Second Floor Dsiidc Shed, Okhla Industrial Area, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.85 Cr, a growth of 55% compared to the previous year. For the same year it recorded a net profit of ₹51.93 Lakh (net margin 3.5%) and EBITDA of ₹1.07 Cr (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 73% over three years and 134% over five years.
The company has about 29 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹20 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.
For more details, the company can be reached via its website malookpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressBuilding No 19 Second Floor Dsiidc Shed, Okhla Industrial Area, New Delhi, Delhi, India – 110020
- IndustryE-Commerce, Online Healthcare Product Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Malook Pharmaceuticals Private Limited
The main business activity of Malook Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Malook Pharmaceuticals Private Limited FY 2025 filings available
Malook Pharmaceuticals Private Limited reported revenue of ₹14.85 Cr (up 55% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Malook Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 134% over five years, including 55% growth in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Malook Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.07 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹51.93 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Malook Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Malook Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Malook Pharmaceuticals Private Limited
Malook Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Ecommerce and Internet industry (Healthcare Products, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Grindlays Pharmaceuticals Pvt Ltd | ₹14.96 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | Mumbai, Maharashtra, India |
| Centenarians Life Sciences Private Limited | ₹14.93 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Surat, Gujarat, India |
| Raymed Pharmaceuticals Limited | ₹14.9 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Chandigarh, India |
| Nexgenrx Pharmaceuticals Private Limited | ₹14.89 Cr (FY 2024) | •••• | •••• | 53.0% | •••• | New Delhi, Delhi, India |
| Beref Pharmaceuticals Private Limited | ₹14.86 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Chennai, Tamil Nadu, India |
| Malook Pharmaceuticals Private Limited this company | ₹14.85 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | New Delhi, Delhi, India |
| Salve Pharmaceuticals Private Limited | ₹14.84 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Prospect Pharmaceuticals Private Limited | ₹14.78 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Bishnupur, West Bengal, India |
| Resonant Pharmaceuticals Private Limited | ₹14.67 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Navagam, Gujarat, India |
| Mackenzie Pharmaceuticals Private Limited | ₹14.66 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Kolkata, West Bengal, India |
| Adhya Pharmaceuticals Private Limited | ₹14.61 Cr (FY 2024) | •••• | •••• | -32.0% | •••• | Roorkee, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Malook Pharmaceuticals by revenue in the Ecommerce and Internet industry (Healthcare Products, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Malook Pharmaceuticals Private Limited
Malook Pharmaceuticals Private Limited is audited by N HARDIA AND ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N HARDIA AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Malook Pharmaceuticals Private Limited
Malook Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita Sharma Also directs: SBB Healthcare Private Limited, Flybug Tourism Private Limited | Director | 08 Jul 2019 | 7 Years 3 Months | Current |
| Shailesh Sharma | Director | 01 Jan 2020 | 6 Years 9 Months | Current |
Ownership and Shareholding of Malook Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Malook Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2025 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Malook Pharmaceuticals Private Limited
Malook Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Malook Pharmaceuticals. All cases are disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (FAO (COMM)) | Filed by the company against Pink Labs Bioscience Private Limited | Disposed |
| District court, South, Delhi | Commercial suit | Filed by the company against an individual | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Malook Pharmaceuticals Private Limited
Malook Pharmaceuticals Private Limited has a workforce of 29 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Malook Pharmaceuticals Private Limited
Malook Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Guman Singh Negi ceased to be Director on 01 Jan 2020.
Credit Ratings, Litigation & Regulatory Alerts for Malook Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Malook Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Malook Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Malook Pharmaceuticals Private Limited
Malook Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAMCM7960N1ZM | Delhi | Active | 13 Aug 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Malook Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Malook Pharmaceuticals Private Limited
Malook Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 08 July 2019 (7+ years old) and is registered under CIN U24302DL2019PTC352339.
Malook Pharmaceuticals reported revenue of ₹14.85 Cr for FY 2025 (up 55% YoY).
Malook Pharmaceuticals has 2 current directors:
- Anita Sharma - Director
- Shailesh Sharma - Director
Malook Pharmaceuticals reported a net profit of ₹51.93 Lakh (net margin 3.5%) and EBITDA of ₹1.07 Cr (EBITDA margin 7.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Malook Pharmaceuticals is 73% over three years and 134% over five years. In the latest year (FY 2025) revenue rose 55%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Malook Pharmaceuticals is 07AAMCM7960N1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Malook Pharmaceuticals is U24302DL2019PTC352339. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Malook Pharmaceuticals has 2 court cases on record: 2 filed by the company. Most are in the high courts.
Malook Pharmaceuticals was incorporated on 08 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Malook Pharmaceuticals by revenue are Grindlays Pharmaceuticals Pvt Ltd, Centenarians Life Sciences Private Limited, Raymed Pharmaceuticals Limited, Nexgenrx Pharmaceuticals Private Limited, Beref Pharmaceuticals Private Limited and 5 more, all in the Ecommerce and Internet industry (Healthcare Products, Pharmaceuticals).
Guman Singh Negi ceased to be Director on 01 Jan 2020. Shailesh Sharma was appointed as Director on 01 Jan 2020. Anita Sharma was appointed as Director on 08 Jul 2019.